Cargando…
The impact of treatment with antidepressants on HBA1c- and LDL levels in type 2 diabetes: A real-world within-subject study
INTRODUCTION: With regard to glycemic control in type 2 diabetes (T2D), treatment with antidepressant drugs is a double-edged sword. Real-world, population-based data on the impact of antidepressant treatment on glycemic control in T2D is absent from the literature. OBJECTIVES: To estimate the impac...
Autores principales: | Rohde, C., Thomsen, R.W., Østergaard, S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9528252/ http://dx.doi.org/10.1192/j.eurpsy.2021.631 |
Ejemplares similares
-
Four‐year HbA1c and LDL‐cholesterol trajectories among individuals with mental disorders and newly developed type 2 diabetes
por: Kristensen, Frederik P., et al.
Publicado: (2021) -
Real-world effectiveness of antidepressant use in persons with schizophrenia: within-individual study of 61,889 subjects
por: Puranen, Arto, et al.
Publicado: (2023) -
Knowledge of HbA1c and LDL‐C treatment goals, subjective level of disease‐related information and information needs in patients with atherosclerotic cardiovascular disease
por: Brockmeyer, Maximilian, et al.
Publicado: (2022) -
Within-subject variation of HbA1c: A systematic review and meta-analysis
por: Gough, Alex, et al.
Publicado: (2023) -
Real‐world practice level data analysis confirms link between variability within Blood Glucose Monitoring Strip (BGMS) and glycosylated haemoglobin (HbA1c) in Type 1 Diabetes
por: Heald, Adrian H., et al.
Publicado: (2018)